Filed: 2/14/2025ACC: 0001104659-25-013740
📋 What this filing means
CATALYS PACIFIC, LLC filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $115.89M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$115.89M
Total AUM (reported)
9.81M
Total Shares
Allocation by class
COM$115.89M100.0%
Portfolio Concentration
Top 3$115.89M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 9.81M
Sole
Full voting authority
9.81M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Mineralys Therapeutics, Inc.
SOLEShares8.64M
TypeSH
Market value$106.41M
91.82%
Sole
8.64M
Shared
0.00
None
0.00
Phathom Pharmaceuticals, Inc.
SOLEShares1.17M
TypeSH
Market value$9.48M
8.18%
Sole
1.17M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Mineralys Therapeutics, Inc.SOLE | COM | 8.64M | SH | $106.41M 91.82% | 8.64M | 0.00 | 0.00 |
Phathom Pharmaceuticals, Inc.SOLE | COM | 1.17M | SH | $9.48M 8.18% | 1.17M | 0.00 | 0.00 |